The global migraine drugs market size reached US$ 3.9 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 5.4 Billion by 2027, exhibiting a growth rate (CAGR) of 5.72% during 2022-2027. More info:- https://www.imarcgroup.com/migraine-drugs-market

1. Copyright © IMARC Service Pvt Ltd. All Rights Reserved
Global Migraine Drugs Market
Research and Forecast Report 2022-
2027
Author: Elena Anderson
Marketing Manager
IMARC Group
© 2022 IMARC All Rights Reserved

2. Report Description
About IMARC Group
International Market Analysis Research and Consulting Group is a leading adviser on
management strategy and market research worldwide. We partner with clients in all regions
and industry verticals to identify their highest-value opportunities, address their most critical
challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological
developments for business leaders in pharmaceutical, industrial, and high technology
organizations. Market forecasts and industry analysis for biotechnology, advanced materials,
chemicals, food and beverage, travel and tourism, nanotechnology and novel processing
methods are at the top of the company’s expertise.
IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and
markets with close cooperation at all levels of the client organization. This ensures that our
clients achieve unmatchable competitive advantage, build more proficient organizations, and
secure lasting results.

3. Report Description
Report Description and Highlights
Global Migraine Drugs Market Research Report 2022-2027:
According to the latest report by IMARC Group, titled “Migraine Drugs Market: Global Industry
Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027”, the global migraine drugs
market is expected to grow at a CAGR of 5.57% during 2022-2027.
Migraine drugs refer to medications that are used to reduce the severity of migraines and prevent
future attacks. A migraine is a severe, neurological disease with a debilitating headache,
characterized by an intense throbbing or pulsing in one area of the head. It is accompanied by
sensitivity to light, sound and smell, visual disturbances such as auras, and nausea or vomiting.
Migraine drugs do not cure migraines; instead, they treat or relieve these symptoms. There are
certain blood pressure medications, as well as some antidepressants, anti-seizure drugs and herbals
that are used to reduce the frequency of migraines.
Request for a PDF sample of this report: https://www.imarcgroup.com/migraine-drugs-
market/requestsample

4. Report Description
Report Description and Highlights
Global Migraine Drugs Market Trends:
According to the Migraine Trust, migraine is the third most common disease globally, with more than
10% of people getting affected by the condition worldwide. This represents the primary factor that has
increased the demand for migraine drugs across the globe. Apart from this, the rising healthcare
expenditure and improving reimbursement policies for migraine medications are also acting as growth-
inducing factors. Besides this, healthcare providers have made significant advancements in the diagnosis
and treatment of migraine.
A more advanced treatment modality with mechanism-based therapies, including supraorbital
transcutaneous stimulation (STS) and transcranial magnetic stimulation, has been introduced as a
preventive therapy for migraine. Additionally, there are many other drugs with novel mechanisms of
action or new therapeutic targets, which are in different development stages.
View Report TOC, Figures and Tables: https://www.imarcgroup.com/migraine-drugs-market

5. Report Description
Report Description and Highlights
Key Market Segmentation
The research report includes the following segments:
Breakup by Treatment Type:
•Abortive Treatment
•Preventive Treatment
Breakup by Drug Type:
•Triptans
•Ergot Alkaloids
•NSAIDs
•Acetylcholine Inhibitors/ Neurotoxins
•Ditans
•CGRP mAbs
•Others
Breakup by Route of Administration:
•Oral
•Injectable
•Others

6. Report Description
Report Description and Highlights
Breakup by Distribution Channel:
•Hospital-Based Pharmacies
•Retail Pharmacies
•Others
Breakup by Region:
•North America
•Asia Pacific
•Europe
•Latin America
•Middle East and Africa

7. Report Description
Report Description and Highlights
Competitive Landscape with Key Players:
•Abbott Laboratories
•Allergan Plc (Abbvie Inc.)
•Amgen Inc.
•AstraZeneca Plc
•Bausch Health Companies Inc. (formerly Valeant Pharmaceuticals)
•Eisai Co. Ltd.
•Eli Lilly and Company
•Endo International Plc
•GlaxoSmithKline Plc
•Johnson & Johnson
•Merck & Co.
•Novartis AG
•Pfizer Inc.
•Sanofi SA
•Teva Pharmaceutical Industries Limited.

8. Report Description
Key Questions Answered in the Report
1. How has the global migraine drugs market performed so far and how will it perform in the
coming years?
2. What has been the impact of COVID-19 on the global migraine drugs market?
3. What are the key regional markets?
4. What is the breakup of the market based on the treatment type?
5. What is the breakup of the market based on the drug type?
6. What is the breakup of the market based on the route of administration?
7. What is the breakup of the market based on the distribution channel?
8. What are the various stages in the value chain of the industry?
9. What are the key driving factors and challenges in the industry?
10. What is the structure of the global migraine drugs market and who are the key players?
11. What is the degree of competition in the industry?

9. Report Description Table of Contents
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Migraine Drugs Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

10. Report Description Table of Contents
6 Market Breakup by Treatment Type
6.1 Abortive Treatment
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Preventive Treatment
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Drug Type
7.1 Triptans
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Ergot Alkaloids
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 NSAIDs
7.3.1 Market Trends
7.3.2 Market Forecast
Click here to visit the complete table of content with list of figures and tables:
https://www.imarcgroup.com/migraine-drugs-market/toc

11. A partial List of our Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
Partial List of Clients

12. A partial List of our Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
Partial List of Clients

13. Report Description
Report Description and Highlights
© 2022 IMARC All Rights Reserved
This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of
International Market Analysis Research and Consulting (IMARC). No part of this publication may be
reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be
used in any form or by and means graphic electronic or mechanical, including photocopying, recording,
taping or by information storage or retrieval, or by any other form, without the express consent of
International Market Analysis Research and Consulting (IMARC).
Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been
based on information and sources believed to be accurate and reliable at the time of publishing.
International Market Analysis Research and Consulting makes no representation of warranty of any kind as to
the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any
loss or damage resulting from opinion, errors or inaccuracies if any found this publication.
IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market
Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of
their respective companies.

14. FOR MORE DETAILS
Visit us at :
Stay With Us:
TELEPHONE: +1-631-791-1145
E-MAIL: sales@imarcgroup.com
https://www.imarcgroup.com
Contact Us